RIGEL PHARMACEUTICALS INC
Customers
4
2 disclosed
Suppliers
0
None disclosed
Largest customer
46%
MCK · 3M to 2026-06-30
Named-customer revenue
$52.7M
2 customers · 3M to 2026-06-30
Latest period
Jun 30, 2026
10-Q filed 2026-08-04
Customers 4
Companies RIGL discloses as major customers, as a share of RIGL revenue. 2 active, 2 lapsed.
| Company | % of RIGL revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| MCK Distributor MCKESSON CORP |
46% | $36.2M | 3M 2026-06-30 | −2.0pp | Active | 10-Q 2026-08-04 |
McKesson Corporation 46 % 31 % 47 % 35 % McKesson Corporation 48 % 43 % 39 % 44 % | ||||||
| COR Distributor Cencora, Inc. |
21% | $16.5M | 3M 2026-06-30 | −2.0pp | Active | 10-Q 2026-08-04 |
Cencora, Inc. 21 % 12 % 22 % 15 % Cencora, Inc. 23 % 19 % 17 % 20 % | ||||||
| Optime Care, Inc. Non-SEC Optime Care, Inc. |
11% | $7.6M | 3M 2025-09-30 | Lapsed Last seen 2025-09-30 |
10-Q 2025-11-04 | |
Optime Care, Inc. 11 % * * * | ||||||
| CAH Distributor CARDINAL HEALTH INC |
10% | $6.9M | 3M 2025-09-30 | −3.0pp | Lapsed Last seen 2025-09-30 |
10-Q 2025-11-04 |
Cardinal Health, Inc. 10 % * * 15 % Cardinal Health, Inc. * 13% Cardinal Health, Inc. * 13 % 25 % | ||||||
Unnamed major customers
Disclosed without names in the fiscal year ending 2018-12-31. Identities are not inferred.
Alerts are coming
Get an email when RIGL's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.